California-based 10X Genomics, a life science technology company, has established a new manufacturing facility and commercial hub in Singapore. The 4,924m2 site features state of the art, automated production suites for reagent manufacturing, a level-2 biosafety lab and a distribution centre as well as supporting warehouse space and open office areas.

The new hub is 10x Genomics’ first overseas manufacturing facility. The opening forms part of ongoing plans to strengthen the company’s supply chain and better serve customers globally. The Asia-Pacific region is becoming an increasingly important market, representing 25% of the company’s global sales in the first half of 2021.

10x Genomics employs more than 80 staff at the new site in manufacturing, corporate and commercial roles.

The company chose to establish operations in Singapore due to the government’s commitment to the biotechnology industry and business-friendly practices as well as the country’s outstanding manufacturing expertise and strong talent pool.

In a press release, chief executive officer Serge Saxonov commented: “Singapore is a global hub for biotechnology with a thriving innovation ecosystem and strong research community.

“We sincerely thank the Economic Development Board of Singapore for their incredible support and partnership and the 10x teams in Singapore and California for their tremendous efforts in bringing this site online. We are thrilled to grow our presence here and are excited to contribute to Singapore’s culture of science and innovation as we work to fulfil the promise of this century of biology.”